The study reveals stark contrasts between saturated and unsaturated fatty acids at the cellular level with implications for diabetes management.
Year: 2026
Researchers Found Wordle Strategy Winning 99% of the Time Using Shannon Entropy
The mathematical approach maximises information gain per guess rather than targeting the most likely word resulting in near-perfect outcomes.
Scotland’s Wrens May Be Evolving Into New Species Through Island Gigantism Scientists Find
Isolated island populations of wrens are growing measurably larger over generations indicating early-stage speciation through geographic isolation.
DNA Repair Gene EXO1 Becomes Cancer-Promoting When Overproduced Researchers Discover
A gene normally protecting DNA can switch roles and start cleaving DNA dangerously when cells produce too much of it offering a new cancer target.
Scientists Reprogram Brain Immune Cells to Fight Alzheimer’s Using New Molecule OLE
The treatment restored microglia to a protective state reduced toxic plaque buildup and improved memory outcomes in Alzheimer’s disease models.
Yale Long-Term Study Finds Nearly Half of Adults Over 65 Improve Physically or Mentally Over Time
The findings challenge the inevitability of decline in old age showing resilience and improvement are achievable for many older adults.
Eight Common Food Additives Linked to High Blood Pressure and Heart Disease in 112000-Person Study
A major study identified specific preservatives commonly used in processed foods that may significantly raise cardiovascular risk.
Vaping Likely Causes Lung and Oral Cancer Major Review Concludes Based on Biomarker Evidence
Researchers based their conclusion on studies ranging from human biomarkers to animal models finding strong signals of carcinogenicity from nicotine vapes.
GLP-1 Insurance Workaround Guide: What to Do When Your Plan Won’t Cover Weight Loss Drugs
If a doctor prescribes Wegovy but insurance declines the claim there are manufacturer programmes state assistance and alternative coverage options.
American College of Physicians Recommends Semaglutide and Tirzepatide as First-Line Obesity Treatments
A new ACP living guideline elevates GLP-1 drugs Wegovy and Zepbound to first-line recommendations for patients with obesity.